BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 5312811)

  • 1. The coexistence of Sjögren's syndrome and systemic lupus erythematosus.
    Steinberg AD; Talal N
    Ann Intern Med; 1971 Jan; 74(1):55-61. PubMed ID: 5312811
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus.
    Moutsopoulos HM; Klippel JH; Pavlidis N; Wolf RO; Sweet JB; Steinberg AD; Chu FC; Tarpley TM
    Arthritis Rheum; 1980 Jan; 23(1):36-40. PubMed ID: 7352942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus, Sjögren's syndrome and glomerular nephritis.
    Sobel JD; Talor Z; Alroy G; Lichtig C; Valero A
    Postgrad Med J; 1977 Feb; 53(616):97-101. PubMed ID: 876928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histologic aspects of the minor salivary glands in lupus erythematosus].
    Janin A
    Ann Med Interne (Paris); 1990; 141(3):247-9. PubMed ID: 2369015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome in systemic lupus erythematosus. Clinical and subclinical manifestations.
    Alarcón-Segovia D; Ibáñez G; Velázquez-Forero F; Hernández-Ortíz J; González-Jiménez Y
    Ann Intern Med; 1974 Nov; 81(5):577-83. PubMed ID: 4138478
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular-versus-humoral autoimmune responses to salivary gland in Sjögren's syndrome.
    Anderson LG; Tarpley TM; Talal N; Cummings NA; Wolf RO; Schall GL
    Clin Exp Immunol; 1973 Mar; 13(3):335-42. PubMed ID: 4573763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of subclinical atherosclerosis and leukopenia in systemic autoimmune diseases: comment on the article by Huang et al.
    Gerli R; Bocci EB; Shoenfeld Y
    Arthritis Rheum; 2010 Sep; 62(9):2823-4; author reply 2824. PubMed ID: 20533292
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-ribosomal-P antibodies in a Sjögren syndrome patient associated with lupus erythematosus.
    Muro Y; Tomita Y
    J Dermatol; 2004 Oct; 31(10):811-4. PubMed ID: 15672709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome in systemic lupus erythematosus and rheumatoid arthritis: immune effector cells in salivary glands.
    Malmström M; Seppä A; Konttinen YT; Helve T; Reitamo S
    Rheumatol Int; 1983; 3(1):1-5. PubMed ID: 6604304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sjögren's and pseudo Sjögren's syndrome in systemic sclerosis. Experience with 34 patients (author's transl)].
    Aguilera S; Díaz M; Ramírez J
    Rev Med Chil; 1979 Jun; 107(6):497-502. PubMed ID: 545545
    [No Abstract]   [Full Text] [Related]  

  • 15. Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study.
    MacSween RN; Goudie RB; Anderson JR; Armstrong E; Murray MA; Mason DK; Jasani MK; Boyle JA; Buchanan WW; Williamson J
    Ann Rheum Dis; 1967 Sep; 26(5):402-11. PubMed ID: 5341916
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic erythematodes with Sjögrn's syndrome].
    Okuda M; Hirose K; Okamoto S; Nishido T
    Naika; 1971; 28(2):383-8. PubMed ID: 5571663
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases.
    Feltkamp TE; van Rossum AL
    Clin Exp Immunol; 1968 Jan; 3(1):1-16. PubMed ID: 4171044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies and the spectrum of Sjögren's syndrome.
    Martinez-Lavin M; Vaughan JH; Tan EM
    Ann Intern Med; 1979 Aug; 91(2):185-90. PubMed ID: 157095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic lesion in labial salivary glands of patients with systemic lupus erythematosus.
    Skopouli F; Siouna-Fatourou H; Dimou GS; Galanopoulou D; Papadimitriou CS; Moutsopoulos HM
    Oral Surg Oral Med Oral Pathol; 1991 Aug; 72(2):208-12. PubMed ID: 1923400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of patient age and anti-Ro/La antibody status to determine the probability of patients with systemic lupus erythematosus and sicca symptoms fulfilling criteria for secondary Sjögren's syndrome.
    Prabu A; Marshall T; Gordon C; Plant T; Bawendi A; Heaton S; Jobson S; Briggs D; Bowman SJ
    Rheumatology (Oxford); 2003 Jan; 42(1):189-91. PubMed ID: 12509639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.